326 related articles for article (PubMed ID: 35955873)
21. [Mechanisms of osteoporosis development in patients with rheumatoid arthritis].
Matuszewska A; Szechiński J
Postepy Hig Med Dosw (Online); 2014 Feb; 68():145-52. PubMed ID: 24491906
[TBL] [Abstract][Full Text] [Related]
22. Cellular and molecular pathways of structural damage in rheumatoid arthritis.
Harre U; Schett G
Semin Immunopathol; 2017 Jun; 39(4):355-363. PubMed ID: 28597065
[TBL] [Abstract][Full Text] [Related]
23. [Rheumatoid arthritis and osteoporosis: trends in their treatments].
Tanaka Y
Nihon Rinsho; 2006 Dec; 64(12):2359-66. PubMed ID: 17154104
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions.
Komatsu N; Takayanagi H
Nat Rev Rheumatol; 2022 Jul; 18(7):415-429. PubMed ID: 35705856
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of selected bone metabolism markers in rheumatoid arthritis patients.
Matuszewska A; Szechiński J
Adv Clin Exp Med; 2013; 22(2):193-202. PubMed ID: 23709375
[TBL] [Abstract][Full Text] [Related]
26. Osteoporosis Pathophysiology, Epidemiology, and Screening in Rheumatoid Arthritis.
Adami G; Saag KG
Curr Rheumatol Rep; 2019 May; 21(7):34. PubMed ID: 31123839
[TBL] [Abstract][Full Text] [Related]
27. Chronic arthritides and bone structure: focus on rheumatoid arthritis-an update.
Messina OD; Vidal M; Adami G; Vidal LF; Clark P; Torres JAM; Lems W; Zerbini C; Arguissain C; Reginster JY; Lane NE
Aging Clin Exp Res; 2023 Jul; 35(7):1405-1416. PubMed ID: 37222927
[TBL] [Abstract][Full Text] [Related]
28. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis.
Romas E; Gillespie MT; Martin TJ
Bone; 2002 Feb; 30(2):340-6. PubMed ID: 11856640
[TBL] [Abstract][Full Text] [Related]
29. Osteoporosis in patients with rheumatoid arthritis: an update in epidemiology, pathogenesis, and fracture prevention.
Raterman HG; Bultink IE; Lems WF
Expert Opin Pharmacother; 2020 Oct; 21(14):1725-1737. PubMed ID: 32605401
[TBL] [Abstract][Full Text] [Related]
30. Osteoporosis in rheumatoid arthritis.
Dequeker J; Maenaut K; Verwilghen J; Westhovens R
Clin Exp Rheumatol; 1995; 13 Suppl 12():S21-6. PubMed ID: 8846540
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms and therapeutic targets for bone damage in rheumatoid arthritis, in particular the RANK-RANKL system.
Tanaka Y; Ohira T
Curr Opin Pharmacol; 2018 Jun; 40():110-119. PubMed ID: 29702364
[TBL] [Abstract][Full Text] [Related]
32. Rheumatoid Arthritis in the View of Osteoimmunology.
Auréal M; Machuca-Gayet I; Coury F
Biomolecules; 2020 Dec; 11(1):. PubMed ID: 33396412
[TBL] [Abstract][Full Text] [Related]
33. The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis.
Edwards CJ; Williams E
Osteoporos Int; 2010 Aug; 21(8):1287-93. PubMed ID: 20229200
[TBL] [Abstract][Full Text] [Related]
34. Biologic therapies and bone loss in rheumatoid arthritis.
Zerbini CAF; Clark P; Mendez-Sanchez L; Pereira RMR; Messina OD; Uña CR; Adachi JD; Lems WF; Cooper C; Lane NE;
Osteoporos Int; 2017 Feb; 28(2):429-446. PubMed ID: 27796445
[TBL] [Abstract][Full Text] [Related]
35. [Bone and calcium metabolism in patients with rheumatoid arthritis].
Furuya T
Clin Calcium; 2011 Sep; 21(9):1369-75. PubMed ID: 21881200
[TBL] [Abstract][Full Text] [Related]
36. [The impact of controlling bone remodeling in rheumatoid arthritis.].
Ebina K
Clin Calcium; 2017; 27(12):1739-1744. PubMed ID: 29179168
[TBL] [Abstract][Full Text] [Related]
37. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
38. [Secondary osteoporosis UPDATE. Rheumatoid arthritis and bone damage: trends in treatment].
Tanaka Y
Clin Calcium; 2010 May; 20(5):735-42. PubMed ID: 20445285
[TBL] [Abstract][Full Text] [Related]
39. Harpagoside attenuates local bone Erosion and systemic osteoporosis in collagen-induced arthritis in mice.
Kim JY; Cheon YH; Ahn SJ; Kwak SC; Chung CH; Lee CH; Lee MS
BMC Complement Med Ther; 2022 Aug; 22(1):214. PubMed ID: 35948905
[TBL] [Abstract][Full Text] [Related]
40. Modeling Rheumatoid Arthritis In Vitro: From Experimental Feasibility to Physiological Proximity.
Damerau A; Gaber T
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33113770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
